Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Laurus Labs
ISIN INE947Q01028
|WKN A2QD6W
Market cap (in EUR)
5,658 m
Country
India
Sector
Healthcare
Dividend yield
0.15%
Overview
Description
Laurus Labs Ltd. develops and manufactures active pharmaceutical ingredients for therapeutic areas of anti-retrovirals and hepatitis C. The company was founded by Dr. Satyanarayana Chava on September 19, 2005 and is headquartered in Hyderabad, India.
Healthcare Healthcare Services Outsourced Development and Manufacturing Services India
Financials
Key metrics
| Market capitalisation, EUR | 5,658 m |
| EPS, EUR | 0.13 |
| P/B ratio | 12.4 |
| P/E ratio | 86.8 |
| Dividend yield | 0.15% |
Income statement (2024)
| Revenue, EUR | 612 m |
| Net income, EUR | 40 m |
| Profit margin | 6.45% |
What ETF is Laurus Labs in?
There are 16 ETFs which contain Laurus Labs. All of these ETFs are listed in the table below. The ETF with the largest weighting of Laurus Labs is the iShares MSCI Emerging Markets Small Cap UCITS ETF.
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.